S106: UBTF-ATXN7L3 GENE FUSION DUE TO 17Q21.31 DELETION DEFINES NOVEL HIGH-RISK ALL SUBTYPE AMENABLE TO MRD-BASED TREATMENT INTENSIFICATION. (23rd June 2022)

• Record Type: Journal Article
• Authors: Bastian, L.; Hartmann, A.; Beder, T.; Hänzelmann, S.; Kässens, J.; Bultmann, M.; Höppner, M. P.; Franzenburg, S.; Wittig, M.; Franke, A.; Nagel, I.; Spielmann, M.; Reimer, N.; Busch, H.; Schwartz, S.; Steffen, B.; Viardot, A.; Döhner, K.; Kondakci, M.; Wulf, G.; Wendelin, K.; Renzelmann, A.; Kiani, A.; Trautmann, H.; Neumann, M.; Gökbuget, N.; Brüggemann, M.; Baldus, C.
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 7
• Page End: 8
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000843320.74833.6a
• Languages: English
• ISSNs: 2572-9241